Citation Impact
Citing Papers
Treatment of Optic Neuritis by Plasma Exchange (Add-On) in Neuromyelitis Optica
2012
The usefulness of immunotherapy in pediatric neurodegenerative disorders: A systematic review of literature data
2015
Response to Therapeutic Plasma Exchange as a Rescue Treatment in Clinically Isolated Syndromes and Acute Worsening of Multiple Sclerosis: A Retrospective Analysis of 90 Patients
2015
The cerebellum and cognition
2018 Standout
Neuromyelitis Optica
2010
Guidelines on the use of therapeutic apheresis in clinical practice—Evidence‐based approach from the apheresis applications committee of the American Society for Apheresis
2010
Applying genomic and transcriptomic advances to mitochondrial medicine
2021
Update on investigation and management of postinfectious encephalitis
2010
Hallmarks of aging: An expanding universe
2023 Standout
Purification and Identification of Activating Enzymes of CS-0777, a Selective Sphingosine 1-Phosphate Receptor 1 Modulator, in Erythrocytes
2011
Novel therapies for immune-mediated inflammatory diseases: What can we learn from their use in rheumatoid arthritis, spondyloarthritis, systemic lupus erythematosus, psoriasis, Crohn's disease and ulcerative colitis?
2017
Mammalian ceramide synthases
2010 Standout
Diagnosis of multiple sclerosis: progress and challenges
2016
Identification of a Metabolizing Enzyme in Human Kidney by Proteomic Correlation Profiling
2013
MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis—clinical implementation in the diagnostic process
2015
Therapeutic Plasma Exchange in Patients with Neurologic Disorders: Review of 63 Cases
2016
The role of the cerebellum in multiple sclerosis—150 years after Charcot
2018
Role of proinflammatory cytokines in the pathophysiology of osteoarthritis
2010 Standout
Therapeutic plasma exchange in treatment of neuroimmunologic disorders: Review of 92 cases
2013
Is it time to target no evident disease activity (NEDA) in multiple sclerosis?
2015
Development, maintenance and disruption of the blood-brain barrier
2013 Standout
Short delay to initiate plasma exchange is the strongest predictor of outcome in severe attacks of NMO spectrum disorders
2017
Revised Recommendations of the Consortium of MS Centers Task Force for a Standardized MRI Protocol and Clinical Guidelines for the Diagnosis and Follow-Up of Multiple Sclerosis
2015
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
2011 Standout
Defining Disease Activity and Response to Therapy in MS
2017
Ulcerative colitis
2020 Standout
Ceramide Synthesis Is Modulated by the Sphingosine Analog FTY720 via a Mixture of Uncompetitive and Noncompetitive Inhibition in an Acyl-CoA Chain Length-de pend ent Manner
2009
Neurologic indications for therapeutic plasma exchange: 2011 update
2012
Multiple Sclerosis: New Insights in Pathogenesis and Novel Therapeutics
2011
Beneficial Plasma Exchange Response in Central Nervous System Inflammatory Demyelination
2011
Accurate Proteome-wide Label-free Quantification by Delayed Normalization and Maximal Peptide Ratio Extraction, Termed MaxLFQ
2014 Standout
Biomarkers in multiple sclerosis
2015
A Review of the ADAMTS Family, Pharmaceutical Targets of the Future
2009
Maintenance plasma exchange therapy for steroid‐refractory neuromyelitis optica
2012
Effect of intramuscular interferon beta-1a on gray matter atrophy in relapsing−remitting multiple sclerosis: A retrospective analysis
2015
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Differences in the Reponses to Apheresis Therapy of Patients With 3 Histopathologically Classified Immunopathological Patterns of Multiple Sclerosis
2018
Clinical Efficacy of Plasmapheresis in Patients with Neuromyelitis Optica Spectrum Disorder and Effects on Circulating Anti-Aquaporin-4 Antibody Levels
2013
Multiple Sclerosis
2018 Standout
Plasma exchange in severe spinal attacks associated with neuromyelitis optica spectrum disorder
2009
Clinical outcomes and predictive factors related to good outcomes in plasma exchange in severe attack of NMOSD and long extensive transverse myelitis: Case series and review of the literature
2017
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice—Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Sixth Special Issue
2013
Therapeutic plasma exchange in neuromyelitis optica: A case series
2013
Natural product and natural product derived drugs in clinical trials
2014 Standout
Outcomes After Early Administration of Plasma Exchange in Pediatric Central Nervous System Inflammatory Demyelination
2014
Andersen–Tawil syndrome: Clinical and molecular aspects
2013
Clinical Practice Guideline: Sudden Hearing Loss (Update)
2019 Standout
Plasma Exchange in Severe Attacks of Neuromyelitis Optica
2012
Monosymptomatic Clinically Isolated Syndrome With Sudden Sensorineural Hearing Loss
2012
Works of Alejandro Horga being referenced
FTY720 (fingolimod) for relapsing multiple sclerosis
2008
Fingolimod for relapsing multiple sclerosis: an update
2010
Genetic association between polymorphisms in the BTG1 gene and multiple sclerosis
2009
Peripheral neuropathy predicts nuclear gene defect in patients with mitochondrial ophthalmoplegia
2014
Clinical features of CIS of the brainstem/cerebellum of the kind seen in MS
2009
Clinical impact of early brain atrophy in clinically isolated syndromes
2013
Measures in the first year of therapy predict the response to interferon β in MS
2009
Early brain pseudoatrophy while on natalizumab therapy is due to white matter volume changes
2013
Natalizumab for relapsing-remitting multiple sclerosis
2011
Value of NMO-IgG determination at the time of presentation as CIS
2012
Prevalence study of genetically defined skeletal muscle channelopathies in England
2013
Brainstem lesions in clinically isolated syndromes
2010
Plasma exchange for acute attacks of CNS demyelination
2009
P39 Prevalence study of skeletal muscle channelopathies in England
2012